
year 4 month 12-14 2023 day, the value of the 88 session of the APIChina held, by the National Pharmaceutical Engineering and National Pharmaceutical Reed Exhibition jointly organized the API Green Smart Factory Forum in Qingdao successfully held.
Green environmental protection is a common challenge and choice faced by mankind. The construction of efficient, green, low-carbon and intelligent pharmaceutical factories has become a necessary path for green development. Internet of things, big data, information technology, artificial intelligence and mobile terminals make green transformation a top priority, accelerate the construction of efficient, green, low-carbon and intelligent pharmaceutical factories, and help the high-quality development of the industry, This forum focuses on this theme.
The five industry experts of Sinopharm Engineering offer advice and suggestions, interpret new policies and regulations, understand the pain points and difficulties of the industry, share new ideas and new ideas, and communicate with pharmaceutical companies, universities, and scientific research institutes.100 the remaining guests jointly explored the road of green and sustainable development of the industry.
Ye Ping, director of the process design office of Sinopharm Engineering Headquarters, focused on the six major goals of medical engineering project construction, from the perspective of engineering design, combined with the classic cases of traditional Chinese medicine modernization projects, shared the practical experience of modern traditional Chinese medicine project engineering design and green intelligent technology application, with pictures and texts, profound and simple, Harvested the wide attention and strong interest of the guests.
Yang Li, director of the Construction Engineering Office of the National Pharmaceutical Engineering Headquarters, made a theme report entitled "The Design Concept and Implementation of the Overall Planning of the Pharmaceutical Green Factory". The report explained and analyzed in detail the national and industry standards and requirements for the construction of green factories, and shared them with specific cases. The overall planning and design concepts, principles and methods of the pharmaceutical green factory were discussed. The speech report resonated strongly with the delegates.
Guo Qiang, deputy director of the Process Design Office of the National Pharmaceutical Engineering Headquarters, took "Large-scale High-level Biosafety Facilities Design" as the topic, from the domestic and foreign laws and regulations to compare the requirements of biosafety isolation, biosafety level 2 and above project design implementation cases, etc. Sharing experience on the design of large-scale high-level biosafety facilities that enterprises are concerned about has formed a good atmosphere of communication and interaction with colleagues.
Zheng Jun, general manager of the marketing department of Sinopharm Engineering, brought a theme report on "Discussion on Three Waste Treatment Technologies and Future Development Trends of Chemical Raw Material Pharmaceutical Enterprises", sorted out the new common environmental protection pain points of API manufacturers, and analyzed the causes of these problems in depth. And the solution, and further discussed the development trend of the three waste treatment technology in the future, the participants responded enthusiastically.
Li Houqiang, deputy general manager of Sinopharm Control Company, made a thematic report entitled "Landing Strategy of Pharmaceutical Digital Factory". From the perspective of pharmaceutical enterprises, he systematically explained how to promote the landing of digital factory more effectively in the form of engineering methodology, so as to better match the implementation effect with the expected goals. His sharing inspired the delegates and benefited greatly.
As the national team and main force of engineering and technical services for China's pharmaceutical and health industry, Sinopharm Engineering has been committed to the research and development and innovation of technologies such as product service quality, intelligent manufacturing, saving and emission reduction, clean production, green factories, digitization and intelligence. Hundreds of pharmaceutical companies have provided overall planning, design and technical services for green factories, digital factories and intelligent manufacturing system solutions. In the future, the National Pharmaceutical Project will continue to make greater contributions to continuously promote the high-quality development of the industry.
(Contributions from Engineering and Technology Department, Market and Operations Management Department)